During the past decade, Centre Jean Perrin conducted 182 clinical trials. In the 10-year time frame, 182 clinical trials started and 20 clinical trials were completed, i.e. on average, 11% percent of trials that started reached the finish line to date. In the past 5 years, 94 clinical trials started and 16 clinical trials were completed. i.e. 17% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Jean Perrin" #1 sponsor was "UNICANCER" with 56 trials, followed by "Centre Jean Perrin" with 40 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 29 trials sponsored, "ARCAGY/ GINECO GROUP" with 17 trials sponsored and "Centre Leon Berard" with 17 trials sponsored. Other sponsors include 146 different institutions and companies that sponsored additional 71 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Jean Perrin" #1 collaborator was "National Cancer Institute, France" with 14 trials as a collaborator, "AstraZeneca" with 12 trials as a collaborator, "Pfizer" with 8 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 7 trials as a collaborator and "Roche Pharma AG" with 7 trials as a collaborator. Other collaborators include 208 different institutions and companies that were collaborators in the rest 159 trials.

According to Clinical.Site data, the most researched conditions in "Centre Jean Perrin" are "Breast Cancer" (48 trials), "Ovarian Cancer" (20 trials), "Metastatic Breast Cancer" (10 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (9 trials) and "Cancer" (7 trials). Many other conditions were trialed in "Centre Jean Perrin" in a lesser frequency.

Most popular intervention types in "Centre Jean Perrin" are "Drug" (200 trials), "Other" (51 trials), "Procedure" (39 trials), "Biological" (28 trials) and "Radiation" (23 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "cyclophosphamide" (11 trials), "fluorouracil" (11 trials), "Pembrolizumab" (10 trials) and "Trastuzumab" (10 trials). Other intervention names were less common.

The vast majority of trials in "Centre Jean Perrin" are 179 trials for "All" genders, 106 trials for "Female" genders and 22 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Jean Perrin". 1 are not yet recruiting, 77 are recruiting, 55 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 132 completed trials in Centre Jean Perrin, 3 suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Jean Perrin, 16 "Phase 1" clinical trials were conducted, 108 "Phase 2" clinical trials and 90 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 64 trials that are defined as “Not Applicable".